ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 210 out of 944

$442K Total Retail Price of All Prescriptions

Rank: 276 out of 944

435 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 462 389 1 2
SIMVASTATIN 442 415 2 1
HYDROCHLOROTHIAZIDE 424 387 3 9
LISINOPRIL 325 282 4 3
METFORMIN HCL 306 247 5 12
OMEPRAZOLE 303 246 6 4
AMLODIPINE BESYLATE 289 275 7 5
ATENOLOL 240 235 8 11
LOSARTAN POTASSIUM 230 202 9 16
METOPROLOL TARTRATE 216 201 10 8
FUROSEMIDE 196 185 11 6
HYDROCODONE-ACETAMINOPHEN 191 139 S3 12 10
PRAVASTATIN SODIUM 183 166 13 17
LOVASTATIN 161 144 14 26
TRAZODONE HCL 158 139 15 45
WARFARIN SODIUM 147 144 16 7
ALENDRONATE SODIUM 130 129 17 20
LOSARTAN-HYDROCHLOROTHIAZIDE 117 117 18 54
SERTRALINE HCL 112 110 19 23
METOPROLOL SUCCINATE 112 103 19 14
FLUTICASONE PROPIONATE 94 82 21 40
TAMSULOSIN HCL 89 87 22 27
BENAZEPRIL HCL 87 77 23 66
FLUOXETINE HCL 86 62 24 48
ATORVASTATIN CALCIUM 82 71 25 13
POTASSIUM CHLORIDE 78 70 26 15
LANTUS 77 77 27 46
ADVAIR DISKUS 77 65 27 31
ZETIA 76 76 29 59
GLIMEPIRIDE 70 57 30 47
CIPROFLOXACIN HCL 67 64 31 90
POLYETHYLENE GLYCOL 3350 63 37 32 41
CLOPIDOGREL 63 55 32 36
PREDNISONE 61 48 34 32
CITALOPRAM HBR 61 21 34 19
OXYCODONE HCL 60 43 S2 36 50
AZITHROMYCIN 60 53 36 70
AMITRIPTYLINE HCL 58 30 R 38 79
CARVEDILOL 58 54 38 30
PEN NEEDLE 56 52 40 100
TRIAMTERENE-HCTZ 55 43 41 33
DONEPEZIL HCL 54 41 42 24
ALLOPURINOL 52 47 43 22
CHLORTHALIDONE 51 40 44 119
ZOLPIDEM TARTRATE 50 46 45 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.